禮來將參加富國銀行第20屆年度醫療保健會議Lilly to participate in Wells Fargo 20th Annual Healthcare Conference

動脈網

2025/08/22

INDIANAPOLIS印第安納波利斯,，Aug. 22, 20252025年8月22日/PRNewswire/ --/PRNewswire/ --Eli Lilly and Company禮來公司(NYSE:LLY) will participate in the Wells Fargo 20th Annual Healthcare Conference on(NYSE:LLY) 將參加富國銀行...

網頁鏈接

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2561470952"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2561470952\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2561470952?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-08-22 21:51","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2561470952","market":"us","top_or_hot":-1,"title":"禮來將參加富國銀行第20屆年度醫療保健會議Lilly to participate in Wells Fargo 20th Annual Healthcare Conference","media":"動脈網","content":"<div>\n<p>INDIANAPOLIS印第安納波利斯,，Aug. 22, 20252025年8月22日/PRNewswire/ --/PRNewswire/ --Eli Lilly and Company禮來公司(NYSE:LLY) will participate in the Wells Fargo 20th Annual Healthcare Conference on(NYSE:LLY) 將參加富國銀行...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082221541094f4cc2f&s=b\">網頁鏈接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>禮來將參加富國銀行第20屆年度醫療保健會議Lilly to participate in Wells Fargo 20th Annual Healthcare Conference</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n禮來將參加富國銀行第20屆年度醫療保健會議Lilly to participate in Wells Fargo 20th Annual Healthcare Conference\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">動脈網</strong><span class=\"h-time small\">2025-08-22 21:51</span>\n</p>\n</h4>\n</header>\n<article>\n<div>\n<p>INDIANAPOLIS印第安納波利斯,，Aug. 22, 20252025年8月22日/PRNewswire/ --/PRNewswire/ --Eli Lilly and Company禮來公司(NYSE:LLY) will participate in the Wells Fargo 20th Annual Healthcare Conference on(NYSE:LLY) 將參加富國銀行...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082221541094f4cc2f&s=b\">網頁鏈接</a>\n\n</div>\n\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082221541094f4cc2f&s=b\">動脈網</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0130102774.USD","symbol_name":"Natixis Harris Associates US Equity RA USD","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082221541094f4cc2f&s=b","article_id":"2561470952","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082221541094f4cc2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2561470952","pubTimestamp":1755870660,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"About Lilly關於禮來公司Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases.禮來是一家醫藥公司，將科學轉化為治療手段，以改善世界各地人們的生活。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0130102774.USD":"Natixis Harris Associates US Equity RA USD","LU1551013342.USD":"Allianz Income and Growth Cl AMg2 DIS USD","LU0130517989.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"R\" INC","LU0466842654.USD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"A\" (USD) ACC","LU0689472784.USD":"安联收益及增长基金Cl AM AT Acc","LU0471298777.SGD":"Blackrock Nutrition A2 SGD-H","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","LU0882574055.USD":"富达全球健康医疗A ACC","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","LU0106261372.USD":"SCHRODER ISF US LARGE CAP \"A\" ACC","SG9999015952.SGD":"LIONGLOBAL DISRUPTIVE INNOVATION \"I\" (SGD) ACC","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","LU0211328371.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (MDIS) (USD)   INC","WFC":"富国银行","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","LU1917777945.USD":"安联专题基金Cl AT Acc","LU0314106906.USD":"MANULIFE GF GLOBAL EQUITY \"AA\" (USD) INC","LU0251131958.USD":"FIDELITY AMERICA \"A\" (USD) ACC","LU0251142724.SGD":"Fidelity America A-SGD","LU0203202063.USD":"AB SICAV I - ALL MARKET INCOME PORTFOLIO \"A2X\" (USD) ACC","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","LU0672654240.SGD":"FTIF - Franklin US Opportunities A Acc SGD-H1","LU2236285917.USD":"ALLIANZ GLOBAL INCOME \"AMG\" (USD) INC","SG9999015986.USD":"LIONGLOBAL DISRUPTIVE INNOVATION \"I\" (USD) ACC","LU1668664300.SGD":"Blackrock World Financials A2 SGD-H","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","LU1868837300.USD":"CT (LUX) I AMERICAN FUND \"9\" (USD) ACC","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","SG9999017495.SGD":"UGDP UNITED GLOBAL QUALITY GROWTH \"B\" (SGD) ACC","LU2491049909.HKD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (HKD) ACC","LU1868836914.USD":"CT (LUX) I AMERICAN \"3\" (USD) ACC","LU0289960550.SGD":"AB FCP I - GLOBAL EQUITY BLEND PORTFOLIO 'A' (SGD) ACC","LU1988902786.USD":"FULLERTON LUX FUNDS GLOBAL ABSOLUTE ALPHA \"I\" (USD) ACC","LU0323591593.USD":"SCHRODER ISF QEP GLOBAL QUALITY \"A\" (USD) ACC","LU0058720904.USD":"联博国际健康护理基金A","LU0787776722.HKD":"AB SELECT US EQUITY PORTFOLIO \"A\" (HKD) ACC","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","LU1267930730.SGD":"富兰克林美国机遇基金AS Acc SGD (CPF)","LU0310800965.SGD":"FTIF - Templeton Global Balanced A Acc SGD","BK4581":"高盛持仓","LU2552382215.SGD":"WELLINGTON US BRAND POWER \"A\" (SGDHDG) ACC","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","LU0256863902.USD":"ALLIANZ US EQUITY \"AT\" (USD) ACC","SGXZ57979304.SGD":"United Global Healthcare A Acc SGD-H","LU2471134952.CNY":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (CNYHDG) INC","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","LU1267930227.SGD":"TEMPLETON GLOBAL BALANCED \"AS\" (SGD) ACC A","LLY":"礼来"},"translate_title":"Eli Lilly to Participate in Wells Fargo's 20th Annual Healthcare Conference Lilly to participate in Wells Fargo 20th Annual Healthcare Conference","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LLY":1,"WFC":1},"content_text":"INDIANAPOLIS印第安納波利斯,，Aug. 22, 20252025年8月22日/PRNewswire/ --/PRNewswire/ --Eli Lilly and Company禮來公司(NYSE:LLY) will participate in the Wells Fargo 20th Annual Healthcare Conference on(NYSE:LLY) 將參加富國銀行第20屆年度醫療保健會議，Sept. 5, 20252025年9月5日.。Patrik Jonsson帕特里克·約翰松, executive vice president and president of，執行副總裁兼總裁Lilly International禮來國際, will take part in a fireside chat at，將參加一場爐邊談話 tại9:30 a.m., Eastern time上午9點30分，東部時間.。A live audio webcast will be available on the 'Webcasts & Presentations' section of Lilly's investor website at現場音頻網絡直播將在禮來公司投資者網站的「網絡直播與演講」部分提供。https://investor.lilly.com/webcasts-and-presentationshttps://investor.lilly.com/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 90 days.演示文稿的重播將在同一網站上提供大約 90 天。About Lilly關於禮來公司Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases.禮來是一家醫藥公司，將科學轉化為治療手段，以改善世界各地人們的生活。近150年來，我們一直在開創改變生命的發現，如今我們的藥物幫助了全球數千萬人。通過利用生物技術、化學和基因藥物的力量，我們的科學家正在加速推進新的發現，以解決一些全球最重要的健康挑戰：重新定義糖尿病護理；治療肥胖症並遏制其最具破壞性的長期影響；推動對抗阿爾茨海默病的鬥爭；為一些最令人衰弱的免疫系統疾病提供解決方案；並將最難治療的癌症轉變為可管理的疾病。With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit .每朝着更健康的世界邁出一步，我們都受到一個目標的激勵：讓數百萬人的生活更美好。這包括開展反映世界多樣性的創新臨床試驗，並努力確保我們的藥品可及且價格合理。欲了解更多信息，請訪問。Lilly.comLilly.comand和Lilly.com/newsLilly.com/新聞, or follow us on，或者關注我們FacebookFacebook,，InstagramInstagram, and，以及LinkedIn領英. F-LLY. F-LLYTrademarks and商標和Trade Names商標名稱All trademarks or trade names referred to in this press release are the property of the company, or, to the extent trademarks or trade names belonging to other companies are references in this press release, the property of their respective owners. Solely for convenience, the trademarks and trade names in this press release are referred to without the ® and ™ symbols, but such references should not be construed as any indicator that the company or, to the extent applicable, their respective owners will not assert, to the fullest extent under applicable law, the company's or their rights thereto.本新聞稿中提到的所有商標或商號均為公司財產，或者，如果引用了屬於其他公司的商標或商號，則為各自所有者的財產。僅為方便起見，本新聞稿中提及的商標和商號未附帶®和™符號，但此類引用不應被解釋為表示公司或在適用範圍內其各自所有者不會根據適用法律全力主張公司或其對該等權利的所有權。We do not intend the use or display of other companies' trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies..我們無意使用或展示其他公司的商標和商號，以暗示我們與其他公司存在關聯，或得到其認可或讚助。Refer to:參考：Ashley Hennessey阿什利·亨尼西;；gentry_ashley_jo@lilly.comgentry_ashley_jo@lilly.com; 317-416-4363 (Media)；317-416-4363（媒體）Michael Czapar;邁克爾·查帕爾；czapar_michael_c@lilly.comczapar_michael_c@lilly.com; 317-617-0983 (Investors)；317-617-0983（投資者）View original content to download multimedia:查看原始內容以下載多媒體：https://www.prnewswire.com/news-releases/lilly-to-participate-in-wells-fargo-20th-annual-healthcare-conference-302536339.htmlhttps://www.prnewswire.com/news-releases/禮來將參加富國銀行第20屆年度醫療保健會議-302536339.htmlSOURCE源代碼Eli Lilly and Company禮來公司","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"conferences","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}